Skip to main content
SpringerLink
Log in

Bilanz der Chemotherapie der Tuberkulose

  • Published:
Pneumonologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  • American Thoracic Society: Ethambutol in the treatment of tuberculosis. A statement by the Committee on Therapy. Amer. Rev. resp. Dis.98, 320–321 (1968 a).

    Google Scholar 

  • —— Adrenal corticosteroids and tuberculosis. A statement by the Committee on Therapy. Amer. Rev. resp. Dis.97, 484–485 (1968 b).

    Google Scholar 

  • —— Therapy of pleural effusion. A statement by the Committee on Therapy. Amer. Rev. resp. Dis.97, 479–483 (1968 c).

    Google Scholar 

  • —— Abstracts of papers presented at the Annual Meeting of the ATS held in conjunction with the Meetings of the National Tuberculosis and Respiratory Disease Association and the National Respiratory Disease Conference, May 24–26, 1969. Amer. Rev. resp. Dis.99, 969–971 (1969 a).

    Google Scholar 

  • —— A statement by the Committee on Therapy: Intermittent chemotherapy for tuberculosis. Amer. Rev. resp. Dis.100, 257–259 (1969 b).

    Google Scholar 

  • Batten, J. C.: Rifampicin in treatment of experimental tuberculosis in mice. Tubercle (Lond.)50, 294–298 (1969).

    PubMed  Google Scholar 

  • —— Rifampicin in the treatment of experimental tuberculosis in mice: Sterilization of tubercle bacilli in the tissues. Tubercle (Lond.)51, 95–99 (1970).

    PubMed  Google Scholar 

  • Bek, E., Bukalska, Z., Stachlewska, S. Zachara, A.: Criteria of inactivity in pulmonary tuberculosis with correct chemotherapy. Gruźlica36, 897–901 (1968).

    Google Scholar 

  • Bernard, E.: Traitement des tuberculoses pulmonaires invétérées (hyperchroniques) à bacilles résistants, par la polychimiothérapie antibacillaire. Bull. Un. int. Tuberc.41, 183–185 (1968).

    Google Scholar 

  • Bethlem, N., Mendes, W.: Blind treatment of tuberculosis with second-line drugs. Hospital (Rio)74, 5 (1968).

    Google Scholar 

  • Bignall, J. R., Lind, A., et Coll.: Comparaison des régimes d'éthionamide, de pyrazinamide et de cyclosérine dans le traitement de malades atteints de tuberculose pulmonaire et déjà traités antérieurement. Bull. Un. int. Tuberc.42, 7–64 (1969).

    Google Scholar 

  • Böszörményi, M., Fauszt, I., Károlyi, A., Seri, I., Vámos, K.: Nos premières expériences cliniques sur la rifampicine. Acta tuberc. pneumol. belg.60, 471–477 (1969).

    PubMed  Google Scholar 

  • British Medical Research Council: Emergence of bacterial resistance in pulmonary tuberculosis under treatment with isoniazid, streptomycin plus PAS, streptomycin plus PAS and streptomycin plus isoniazid. Lancet1953 aII, 217–223.

    Google Scholar 

  • —— Laboratory techniques for the determination of sensitivity of bacilli to isoniazid, streptomycin and PAS. Lancet1953 bII, 213–217.

    Google Scholar 

  • —— Isoniazid in the treatment of pulmonary tuberculosis. Brit. med. J.1953 cI, 521–536.

    Google Scholar 

  • —— Long-term chemotherapy in the treatment of chronic pulmonary tuberculosis with cavitation. Tubercle (Lond.)43, 201–368 (1962).

    Google Scholar 

  • British Tuberculosis Association: A trial of corticotrophin and prednisone with chemotherapy in pulmonary tuberculosis. Tubercle (Lond.)42, 391–412 (1961).

    Google Scholar 

  • —— A comparison of the toxicity of prothionamide and ethionamide. Tubercle (Lond.)49, 125–135 (1968).

    Google Scholar 

  • Brocard, H., Akoun, G., Depierre, A., Muon, N., Tobé, F. M.: La rifampicine dans le traitement de la tuberculose pulmonaire. A propos de 40 observations. Rev. Tuberc. (Paris)33, 173–176 (1969).

    Google Scholar 

  • Brouet, G.: Action thérapeutique des nouveaux antibiotiques. Critères d'activité. Seizième Congrès National de la Tuberculose et des Maladies Respiratoires, Bordeaux, 2, 3 et 4 Avril 1970, pp. 263, pp. 163–200. Paris: Masson et Cie 1970.

    Google Scholar 

  • —— Marche, J., Rist, N., Chevalier, J., Le Meur, G.: Thioamide de l'acide alpha-éthylisonicotinique (1314 TH). Étude clinique. Bull. Un. int. Tuberc.28, 228–240 (1958).

    Google Scholar 

  • —— Modai, J., Vergez, P.: Essais cliniques de la rifampicine en monothérapie. Rev. Tuberc. (Paris)33, 121–132 (1969).

    Google Scholar 

  • Canetti, G., Grosset, J.: Teneur des souches sauvages de Mycobacterium tuberculosis en variants résistants à l'isoniazide et en variants à la streptomycine sur milieu de Loewenstein-Jensen. Ann. Inst. Pasteur101, 28–46 (1961).

    Google Scholar 

  • —— —— Mésure de la sensibilité du bacille tuberculeux aux drogues antibacillaires par la méthode des proportions. Rev. Tuberc. (Paris)27, 217–272 (1963).

    Google Scholar 

  • —— Grumbach, F., Grosset, J.: Long-term two stage chemotherapy of advanced experimental murine tuberculosis with intermittent regimes during the second stage. Tubercle (Lond.)44, 236–240 (1963).

    PubMed  Google Scholar 

  • —— Le Lirzin, M., Porven, G.: Comparaison entre la rifampicine et l'isoniazide. Dilutions inhibitrices minimales du sérum de l'homme aux doses thérapeutiques habituelles. Rev. Tuberc. (Paris)33, 91–94 (1969 a).

    Google Scholar 

  • —— —— —— Le Lirzin, M. Proven, G. Rist, N., Grumbach, F.: Some Comparative Aspects of Rifampicin and Isoniazid. Tubercle (Lond.)49, 367–376 (1968).

    PubMed  Google Scholar 

  • —— Parrot, R., Porven, G., Le Lirzin, M.: Les taux de rifampicine dans le poumon et dans les lésions tuberculeuses de l'homme. Rev. tuberc. pneumol. belg.60, 315–322 (1969 b).

    Google Scholar 

  • Chaulet, P., Larbaoui, D., Grosset, G., Abderrahim, K.: Intermittent Chemotherapy with Isoniazid and Streptomycin in Algiers. Tubercle (Lond.)48, 128–136 (1967).

    PubMed  Google Scholar 

  • Cheung, O. T., Pugsley, H. E.: A Follow-Up Study of 134 Cases of Pulmonary Tuberculosis Treated with Adequate Chemotherapy in 1953–1954. Canad. Med. Ass. J.98, 1182–1183 (1968).

    PubMed  Google Scholar 

  • Chicou, F. J., Hétrick, G., Huet, M., Radenac, H., Rist, N.: Comparison of two regimens of oral treatment of pulmonary tuberculosis (ethionamid plus isoniazid, thioacetazone plus isoniazid). Bull. W.H.O.39, 731–769 (1968).

    PubMed  Google Scholar 

  • Citron, K. M., May, J. R.: The rifampicin in purulent bronchitis. Tubercle (Lond.)50, 329 (1969).

    Google Scholar 

  • Constans, P., Morin, Y., Saint-Paul, M., Bonnaud, G., Coury, C., Bariéty, M.: L'association rifampicine-isoniazide. Résultats bactériologiques et radiocliniques du traitement de 56 tuberculoses pulmonaires récentes. Rev. Tuberc. (Paris)33, 147–154 (1969).

    Google Scholar 

  • —— Saint-Paul, M., Morin, Y., Bonnaud, G., Bariéty, M.: Etude des taux plasmatiques de rifampicine et de leurs variations (440 dosages). Rev. tuberc. pneumol. belg.60, 299–314 (1969).

    Google Scholar 

  • Corpe, R. F., Blalock, F. A., In: The twenty-seventh Veterans Administration-Armed Forces Pulmonary Disease Research Conference (Report by E. Rothstein). Amer. Rev. resp. Dis.97, 949 (1968).

    Google Scholar 

  • —— —— A continuing study of patients with „Open-Negative“ status at Battey State Hospital. Amer. Rev. resp. Dis.98, 954–964 (1968).

    PubMed  Google Scholar 

  • Crofton, J., In: La signification clinique des mesures de résistance bactérienne. Bull. Un. int. Tuberc.27, 213–279 (1957).

    Google Scholar 

  • —— Chemotherapy of pulmonary tuberculosis. Brit. med. J.1, 1610 (1959).

    Google Scholar 

  • —— Treatment of patients with drug-resistance in economically developped countries. Tubercle (Lond.) Suppl.50, 65–68 (1969).

    Google Scholar 

  • Curry, F. J.: Neighborhood clinics for more effective outpatient treatment of tuberculosis. New Engl. J. Med.279, 1262–1267 (1968).

    PubMed  Google Scholar 

  • Daddi, G., Cornia, G., Grassi, C., Perna, G., Scarpazza, G.: Prime osservazioni sull attività della rifampicina per via orale nella tubercolosi polmonare cronica. Atti del XVIII Congresso Italiano di Tisiologia, Milano, 4-5-6-novembre 1966, vol. 2, pp. 531–532.

  • —— Lucchesi, M., Mancini, P.: La rifampicina nel trattamento intermittente della tubercolosi sperimentale della cavia. Ann. Ist. C. Forlanini29, 35–40 (1969).

    Google Scholar 

  • —— —— —— Matzeu, M., Rossi, P.: La rifampicina-sensibilità dei micobatteri. Ann. Ist. C. Forlanini29, 17–28 (1969).

    Google Scholar 

  • —— —— —— Termine, A.: La virulenza dei ceppi di mycobacterium tuberculosis resistenti alla rifampicina. Ann. Ist. C. Forlanini29, 29–33 (1969).

    Google Scholar 

  • —— —— Rossi, P., Sbampato, M.: La rifampicina nel trattamento della tubercolosi polmonare. Ann. Ist. C. Forlanini29, 3–16 (1969).

    Google Scholar 

  • Delaude, A., Monnier, J., Albarède, J. L., Bourse, R., Puel, J. Mme: La rifampicine dans le traitement de la tuberculose pulmonaire (Premiers résultats). Rev. Tuberc. (Paris)33, 155–162 (1969).

    Google Scholar 

  • Destexhe, G. E.: Reprise du traitement par la rifampicine de cas résistants de tuberculose pulmonaire. Acta tuberc. pneumol. belg.60, 501–506 (1969).

    PubMed  Google Scholar 

  • Devadatta, S., Menon, N. K., Nazareth, O., Dahakrishna, S., Ramakrishnan, C. V., Somasundaram, P. R., Usha, S. P., Velu, S.: A doubleblind study to determine the maximum tolerated dose of ethionamide, when administered twice-weekly to patients with pulmonary tuberculosis. Tubercle (Lond.)51, 263–269 (1970).

    PubMed  Google Scholar 

  • Dickinson, J. M., Ellard, G. A., Mitchison, D. A.: Suitability of isoniazid and ethambutol for intermittent administration in the treatment of tuberculosis. Tubercle (Lond.)49, 351–366 (1968).

    PubMed  Google Scholar 

  • —— Mitchison, D. A.: In vitro and animal experiments with rifampicin. Tubercle (Lond.)50, 327 (1969).

    Google Scholar 

  • —— —— Suitability of rifampicin for intermittent administration in the treatment of tuberculosis. Tubercle (Lond.)51, 82–94 (1970).

    PubMed  Google Scholar 

  • Dissmann, E.: La culture sur lames — méthode rapide de mesure de la résistance du bacille tuberculeux aux médicaments. Bull. Un. int. Tuberc.31, 73–87 (1961).

    Google Scholar 

  • Doust, J. Y., Moatamed, F.: Retreatment program in pulmonary tuberculosis with resistant mycobacteria in South of Iran. Dis. Chest52, 21–23 (1967).

    PubMed  Google Scholar 

  • Durante, C., Burzoni, F. J.-M.: Results of a study of the treatment of pulmonary tuberculosis with combined isoniazid and thiacetazone in the province of Marrakech (Morocco). Rev. Tuberc. (Paris)32, 894–859 (1968).

    Google Scholar 

  • East African/British Medical Research Council Fifth Thiazetazone Investigation: Isoniazid with thiacetazone (thioacetazone) in the treatment of pulmonary tuberculosis in East-Africa-Fifth Investigation. Tubercle (Lond.)51, 123–151 (1970).

    Google Scholar 

  • East African/British Medical Research Council's Investigation: The results from twelve to thirty-six months in patients submitted to two studies of primary chemotherapy for pulmonary tuberculosis in East Africa. Tubercle (Lond.)50, 233–256 (1969).

    Google Scholar 

  • East African/British Medical Research Council Kenya Tuberculosis Survey Follow-up: Tuberculosis in Kenya: a follow-up of a national sampling survey of drug resistance and other factors. Tubercle (Lond.)51, 1–23 (1970).

    Google Scholar 

  • East African/British Medical Research Council Pyrazinamide Investigation: A controlled comparison of four regimes of streptomycin plus pyrazinamide in the retreatment of pulmonary tuberculosis. Tubercle (Lond.)50, 81–114 (1969).

    Google Scholar 

  • Emerson, P. A., Lacey, R. W., Breach, M. R.: A bacteriological study of thiocarlide monotherapy. Tubercle (Lond.)50, 273–279 (1969).

    PubMed  Google Scholar 

  • Espié, J.: Présentation des résultats obtenus lors du traitement de 423 tuberculeux pulmonaires par la rifampicine. Rev. Tuberc. (Paris)33, 307–314 (1969).

    Google Scholar 

  • Favez, G., Willa, Cl.: Observations préliminaires sur l'emploi de la rifampicine dans le traitement de la tuberculose pulmonaire. Rev. Tuberc. (Paris)33, 199–206 (1969).

    Google Scholar 

  • Fischer, D.-A., Lester, W., Dye, W. E., Moulding, Th. S.: Re-treatment with isoniazid-resistant tuberculosis. Amer. Rev. resp. Dis.97, 392–398 (1968).

    PubMed  Google Scholar 

  • —— —— Schaeffer, W. B.: Infections with atypical mycobacteria. Five year's experience at the National Jewish Hospital. Amer. Rev. resp. Dis.98, 29–34 (1968).

    PubMed  Google Scholar 

  • Figueiredo, F. P. de: Treatment of patients with pulmonary tuberculosis classified according to the history of previous chemotherapy and without reference to pretreatment drug sensitivity. Tubercle (Lond.)50, 335–343 (1969).

    PubMed  Google Scholar 

  • Fox, W.: The John Barnwell lecture — Changing concepts in the chemotherapy of pulmonary tuberculosis. Amer. Rev. resp. Dis.97, 767–790 (1968).

    PubMed  Google Scholar 

  • —— Problems of treatment of drug resistance in the developping countries. Tubercle (Lond.)50, 55–65 (1969).

    PubMed  Google Scholar 

  • —— Robinson, D. K., Tall, R., Mitchison, D. A., Kent, P. W., Macfadyen, D. N.: A study of acute intolerance to ethionamide, including a comparison with prothionamide, and the influence of a vitamin B-complex additive in prophylaxis. Tubercle (Lond.)50, 125–143 (1969).

    PubMed  Google Scholar 

  • Freerksen, E.: Introductive remarks on rifampicin. Acta tub. pneumol. belg.60, 251–253 (1969).

    Google Scholar 

  • —— Fortschritte in der Tuberkulose-Behandlung. Isoniazid + Rifampicin + Myambutol als neue “Standardtherapie”. Dtsch. med. Wschr.95, 139–141 (1970).

    PubMed  Google Scholar 

  • Freerksen, E., Orlowski, E.-H.: Tuberkulose 1970 — Eine Zwischenbilanz. Deutsche Rentenversicherung, pp. 261–267 (1970).

  • —— Rosenfeld, M., Orlowski, E.-H.: Isoniazid + Rifampicin + Myambutol, eine neue Standard-kombination für die medikamentöse Behandlung der Tuberkulose. Beitr. Klin. Tuberk.141, 273–296 (1970).

    Google Scholar 

  • Frenkel, S., Wójcik, B., Jaworski, J.: The fate of tuberculous patients with the “open-negative” syndrome. Gruźlica36, 451–454 (1968).

    Google Scholar 

  • Gernez-Rieux, C., Tacquet, A., Fournier, P., Macquet, V.: Notre expérience du 1314 Th (Trécator) dans le traitement de la tuberculose pulmonaire. Lille méd.5, 53–60 (1960).

    Google Scholar 

  • —— —— Devulder, B., Debruyne, J.: Les mycobactérioses humaines. Méthodes actuelles de diagnostic bactériologique. Aspects cliniques, thérapeutiques et épidémiologiques. Seizième Congrès National de la Tuberculose et des Maladies Respiratoires, Bordeaux, 2, 3 et 4 Avril 1970, p. 263, pp. 1–70. Paris: Masson et Cie 1970.

    Google Scholar 

  • Goldman, K. P.: Treatment of unclassified mycobacterial infection of the lungs. Thorax (Lond.)23, 94–99 (1968).

    PubMed  Google Scholar 

  • Govindaraj, M.: Multiple-drug reactions in tuberculosis — an illustrative case. Tubercle (Lond.)49, 416–418 (1968).

    PubMed  Google Scholar 

  • Grassi, C. (avec la collaboration d'autres): Traitement des cas de tuberculose chronique avec éthambutol et prothionamide associés à rifampicine ou capréomycine. Rev. Tuberc. (Paris)33, 225–230 (1969).

    Google Scholar 

  • Grumbach, F.: Comparaison entre la rifampicine et l'isoniazide — Activité expérimentale chez la souris. Rev. Tuberc. (Paris).33, 53–58 (1969 a).

    Google Scholar 

  • —— Experimental (in vivo) studies of new antituberculous drugs: capreomycin, ethambutol, rifampicin. Tubercle (Lond.) Suppl.50, 12–21 (1969 b).

    PubMed  Google Scholar 

  • —— La rifampicine dans les traitements associés, continus et intermittents de la tuberculose expérimentale de la souris. Acta tuberc. pneumol. belg.60, 390–396 (1970).

    Google Scholar 

  • —— Canetti, G., Le Lirzin, M.: Rifampicin in daily and intermittent treatment of experimental murine tuberculosis, with emphasis on late results. Tubercle (Lond.)50, 280–293 (1969).

    PubMed  Google Scholar 

  • —— Rist, N.: Activité antituberculeuse expérimentale de la rifampicine, dérivé de la rifamycine SV. Rev. Tuberc. (Paris)31, 749 (1967).

    Google Scholar 

  • Gyselen, A., Simon-Pouthier, F.: Clinical results in first treatment and retreatment of advanced pulmonary tuberculosis with rifampicin. Tubercle (Lond.)50, 328–329 (1969).

    Google Scholar 

  • —— Verbist, L., Cosemans, J., Lacquet, L. M., Prignot, J., Simon-Pouthier, F., Brabandere, R. de, Devriendt, J.: A cooperative study on rifampicin in original treatment of advanced pulmonary tuberculosis. Acta tuberc. pneumol. belg.60, 563–576 (1969).

    PubMed  Google Scholar 

  • —— —— —— —— Vandenbergh, E.: Rifampicin and ethambutol in the retreatment of advanced pulmonary tuberculosis. Amer. Rev. resp. Dis.68, 933–943 (1968).

    Google Scholar 

  • —— —— Simon-Pouthier, F., Prignot, J., Brabandere, R. de: La rifampicine dans le traitement d'attaque de la tuberculose pulmonaires (Résultats préliminaires d'une étude comparative). Rev. Tuberc. (Paris),33, 133–134 (1969).

    Google Scholar 

  • Havel, A., Adámak, L., Šimonová, S.: Rifampicin in experimental investigations on mice. Antibiotica et Chemotherapia, vol. 16, pp. 406–415. Basel-München-New York: Karger 1970.

    Google Scholar 

  • —— —— The effect of capreomycin on “atypical” and avian mycobacterial strains in vitro. Antibiotica et Chemotherapia, vol. 16, pp. 17–19. Basel-München-New York: Karger 1970.

    Google Scholar 

  • Heinivaara, O., Lindeberg, L., Pätiälä, J.: The frequency of postpleuritic tuberculosis. Scand. J. resp. Dis. Suppl.72, 42–44 (1970).

    Google Scholar 

  • Hertzog, P., Toty, L., Personne, C., Chevassu, J.: Homolateral relapse after upper, segmental or lobar resections for tuberculosis: A clinical follow-up study. Rev. Tuberc. (Paris)31, 5–16 (1967).

    Google Scholar 

  • Hollins, J. P., Simmons, A. V.: Jaundice associated with rifampicin. Tubercle (Lond.)51, 328–332 (1970).

    PubMed  Google Scholar 

  • Horne, N. W.: Drug-resistant tuberculosis: a review of the world situation. Tubercle (Lond.) Suppl.50, 2–12 (1969).

    PubMed  Google Scholar 

  • Horwitz, O.: Public health aspects of relapsing tuberculosis. Amer. Rev. resp. Dis.99, 183–193 (1969).

    PubMed  Google Scholar 

  • Høyer, I.: Prognosis of pulmonary tuberculosis in diabetes before and after induction of chemotherapy. Scand. J. resp. Dis. Suppl.74 11 (1970).

    Google Scholar 

  • Hutás, I., Nyiredy, G.: Comparative function studies in cases of exsudative pleurisy treated with and without corticosteroids. Acta tuberc. scand.38 12–17 (1960).

    PubMed  Google Scholar 

  • Jančík, E.: The treatment of pulmonary tuberculosis in patients harbouring bacilli resistant to the three major drugs. Symposium held in Paris on September 8, 1960 and presided over by E. Jančik (Czechoslovakia), Members: N. W. Horne (Great Britain), Prof. B. Kreis (France), Prof. M. Lucchesi (Italy), J. W. Raleigh (U.S.A.) and Prof. M. Zierski (Poland). Bull. int. Tuberc.31 4–60 (1961).

    Google Scholar 

  • -- Ethionamid treatment in Czechoslovakia: A preliminary report. Trans 21st Res. Conf. pulm. Dis. VA-AF (St. Louis) 311–321 (1962).

  • —— Etude comparative des résultats obtenus par les associations chimiothérapiques majeures chez des malades à bacilles de résistance basse et chez des malades à bacilles de résistance élevée, à la même drogue. Bull. Un. int. Tuberc.33 100–119 (1963).

    Google Scholar 

  • —— Die Behandlung von Lungentuberkulosekranken mit resistenten Tuberkelbazillen. Z. Tuberk.122 131–140 (1964 a).

    PubMed  Google Scholar 

  • —— Effects des agents antibacillaires dits secondaires sur la tuberculose pulmonaire. Progr. Explor. Tuberc., vol. 13, pp. 121–218. Basel-München-New York: Karger 1964b.

    Google Scholar 

  • —— Meilleurs régimes chimiothérapiques chez les malades déjà traités dont les bacilles sont résistants aux drogues antibacillaires majeures. Bull. Un. int. Tuberc.35 165–170 (1964 c).

    Google Scholar 

  • —— Die Behandlung von Tuberkulosekranken mit resistenten Tuberkelbazillen. Wien. med. Wschr.116 925–929 (1966).

    PubMed  Google Scholar 

  • —— Methods and fight against chronic tuberculosis in Czechoslovakia. Scand. J. resp. Dis. Suppl.65 105–111 (1968).

    Google Scholar 

  • —— The use of ethambutol in clinical practice. Tubercle (Lond.) Suppl.50 52–54 (1969).

    Google Scholar 

  • —— Boučková, I., Jančíková, M., Novák, M.: Clinical and laboratory experiences with cycloserine. Scand. J. resp. Dis. Suppl.71 306–313 (1970).

    Google Scholar 

  • —— Novák, M., Jančiková, M., Toušek, J., Krátký, J., Feitová, S., Zelenka, M.: Quelques aspects concernant de nouvelles associations de drogues dans le traitement de la tuberculose à bacilles résistants. Bull. Un. int. Tuberc.41 188–191 (1969).

    Google Scholar 

  • Japan: Cooperative Study Unit on Chemotherapy of Tuberculosis of National Sanatoria in Japan (Chairman S. Sunahara): Comparison of single, double, and triple drug regimens in the re-treatment of drug-resistant pulmonary tuberculosis. Seventh Series of Trial, Part B. Kekkaku43 199–207 (1968).

    Google Scholar 

  • Japan: A Statement by the Tuberculosis Treatment Research Committee. Kekkaku 1970 a.

  • Japan: Cooperative Study group of the Japanese National Sanatoria on Atypical Mycobacteria: A study on the frequency of “atypical” mycobacteria in Japanese National sanatoria. Tubercle (Lond.)51 270–279 (1970).

    Google Scholar 

  • Johanson, W. G., Jr., Nicholson, D. P.: Pulmonary Disease Due to Mycobacterium Kansasii. An analysis of some factors affecting prognosis. Amer. Rev. resp. Dis.99 73–85 (1969).

    PubMed  Google Scholar 

  • Kopeć, H.: Early relapses in inactive pulmonary tuberculosis. Gruźlica37 235–242 (1969).

    Google Scholar 

  • Kraan, J. K., Mulder, R. J.: Ethambutol in the treatment of tuberculosis. Antibiotica et chemotherapia, vol. 1c, pp. 278–280. Basel-München-New York: Karger 1970.

    Google Scholar 

  • —— —— van Dijk, B.: Controlled study on rifampicin in first treatment of fresh cases of pulmonary tuberculosis. Acta tuberc. pneumol. belg.60 557–562 (1969).

    PubMed  Google Scholar 

  • Kreis, B.: Résistance et survivance du bacille tuberculeux aux médications antibacillaires, pp. 734 (siehe S. 672). Paris: Masson et Cie 1966.

    Google Scholar 

  • —— Conditions d'un traitement ambulatoire correct. Seizième Congrès National de la Tuberculose et des Maladies Respiratoires, Bordeaux 1970, pp. 263, pp. 201–263. Paris: Masson et Cie 1970.

    Google Scholar 

  • Kropp, R., Jungbluth, H., Radenbach, K. L.: Influence of Capreomycin on renal function (preliminary results). Antibiotica et Chemotherapia, vol. 16, pp. 59–68. Basel-München-New York: Karger 1970.

    Google Scholar 

  • Kubín, M., Matušková, E.: Serological typing of mycobacteria for tracing possible sources of avian mycobacterial infection in man. Bull. W. H. O.39 657–662 (1968).

    PubMed  Google Scholar 

  • Lal, S.: Patient's preference of drugs in the treatment of tuberculosis. Tubercle (Lond.)50 269–272 (1969).

    Google Scholar 

  • Lamy, P., Anthoine, D., Vaillant, G., Monneau, J. P., Georges, J. C., Caubel, F., Lambert, H.: Étude préliminaire concernant l'action de la rifampicine dans le traitement des tuberculoses pulmonaires chroniques et des rechutes. Intérêt de l'association rifampicine-éthambutol (à propos de 28 observations). Rev. Tuberc. (Paris)33 bis, 209–222 (1969).

  • Lattimer, J. K.: Our presents aspects of Genitourinary tuberculosis. At the 29 VA-AF Conf., Cincinnati, Jan. 1970. Amer. Rev. resp. Dis.101 787–788 (1970).

    Google Scholar 

  • Leading Article: Rifampicin. Tubercle (Lond.)50 318–320 (1969 a).

    Google Scholar 

  • —— The Twentieth International Tuberculosis Conference. Tubercle (Lond.)50 396–400 (1969 b).

    Google Scholar 

  • Lees, A. W.: Rifampicin toxicity. Tubercle (Lond.)51 222–223 (1970).

    Google Scholar 

  • Lévi-Valensi, A., Porot, M., Léonardon, P., Miguères, J., Dalet, R.: Les accidents neuropsychiatriques survenant les tuberculeux traités par la cyclosérine. Presse méd.66 849–851 (1958).

    Google Scholar 

  • Lim, B. T., Aquinas, M.: Ethambutol and capreomycin in the re-treatment of advanced pulmonary tuberculosis. Amer. Rev. resp. Dis.99 792–793 (1969).

    PubMed  Google Scholar 

  • Lucchesi, M., Mancini, P., Zubiani, M.: Ricerche sperimentali sull'attività antimicobatterica della rimfampicina: 3-/4-metil-1-piperazinil-iminometil-rifamicina SV. Ann. Ist. Forlanini27 119–136 (1967 a).

    PubMed  Google Scholar 

  • —— Pallotta, G., Rossi, P., Sbampato, M.: L'azione terapeutica della rifampicina, derivato 3-/4-metil-1-piperazinil-iminometil-rifamicina SV, nella tubercolosi polmonare. Ann. Ist. Forlanini27 199–227 (1967 b).

    PubMed  Google Scholar 

  • Lukas, W.: Ursachen und Mißerfolge in der stationären Behandlung der offenen Lungentuberkulose und Wege zu ihrer Beseitigung vom Standpunkt des Kostenträgers. Beitr. Klin. Tuberk.140 90–101 (1969).

    Google Scholar 

  • MacDonald, F. M.: In: The Twenty-seventh Veterans Administration-Armed Forces Pulmonary Disease Conference (report by E. Rothstein). Amer. Rev. resp. Dis.97 947 (1968).

    Google Scholar 

  • Malik, S. K., Martin, C. J.: Tuberculosis, corticosteroid therapy, and pulmonary function. Amer. Rev. resp. Dis.100 13–18 (1969).

    PubMed  Google Scholar 

  • Medical Research Council/Miners Chest Disease Treatment Centre: Chemotherapy of pulmonary tuberculosis with pneumoconiosis. Second report to the Medical Research Council from the joint investigators. Tubercle (Lond.)48 1–10 (1967).

    Google Scholar 

  • Meissner, G.: Rifampicin in chronic polyresistant cases of pulmonary tuberculosis. Acta tuberc. pneumol. belg.60 482–486 (1969).

    PubMed  Google Scholar 

  • —— Rifampicin in newly detected, untreated cases of pulmonary tuberculosis. Acta tuberc. pneumol. belg.60 554–556 (1969).

    PubMed  Google Scholar 

  • Meyer, A., Nadjar-Fossé, G.: The association of isoniazid and thiocarlide DAT in the treatment of pulmonary tuberculosis. Comparison with the association of isoniazid and PAS or B-PAS. Rev. Tuberc. (Paris)32 371–380 (1968).

    Google Scholar 

  • Miller, A. B., Nunn, A. J., Tall, R., Mitchison, D. A.: The therapy of pulmonary tuberculosis in Kenya: a comparison of the results achieved in controlled clinical trials with those achieved by the routine treatment Services. Tubercle (Lond.)51 24–38 (1970).

    Google Scholar 

  • Mitchell, R. S., Lester, W.: Clinical experience with cycloserine in the treatment of tuberculosis. Scand. J. resp. Dis. Suppl.71 94–108 (1970).

    Google Scholar 

  • Monaldi, V.: La rifampicina (rifamicina AMP) nelle prime applicazioni terapeutiche. Arch. Tisiol.21 863–866 (1966).

    PubMed  Google Scholar 

  • Morrère, P., Stain, J. P., Chauvet, M. C., Luce, J. P., Leprovost, J.: Essais cliniques de la rifadine (rifampicine). Rev. Tuberc. (Paris)33 bis, 177–198 (1969).

  • Mulder-De Jong, M. T., Mulder, R. J., van Dijk, B.: Enkele waarnemingen betreffende longaandoeningen met atypische mycobacterien. Ned. T. Geneesk.113 2025–2027 (1969).

    Google Scholar 

  • Mulder, R. J., Mulder-De Jong, M. T.: Sterilization of tuberculous lesions in man. Co-report. Exc. Medica Int. Congr. Series, 1970, No.205, 360–363.

  • Murdoch, J. McC., Stewart, S. M.: Viomycin with oxytetracycline in the treatment of pulmonary tuberculosis. Brit. J. Tuberc.50 85–92 (1956).

    Google Scholar 

  • Nasiadko, H.: Stabilization of tuberculosis by ambulatory treatment. Gruźlica36 819–825 (1968).

    Google Scholar 

  • Nitti, V., Ninni, A., Iodice, F.: La mesure de la sensibilité du bacille tuberculeux à la rifampicine (Problèmes techniques et critères des résistances). Rev. Tuberc. (Paris)33 bis, 25–32 (1969).

  • Novák, M., Feitová, S., Allegra, L.: Crescita del M. T. su terreno di Loewenstein-Jensen modificato per acidificazione ai fini dell' esecuzione del test di resistenza alla pirazinamide. Riv. sic. Tuberc. Mal. resp.19 429–439 (1965).

    Google Scholar 

  • —— Krátký, J., Feitová, S.: Assessment of the sensitivity and resistance of M. tuberculosis to pyrazinamide. Stud. pneumol. phtiseol. csl.30 22–28 (1970).

    Google Scholar 

  • Olejníček, M., Weberová, M., Novák, M., Jančík, E.: A controlled trial of isoniazid and 4–4 diisoamyloxythiosemicarbanilide compared with isoniazid and PAS and isoniazid, streptomycin and PAS. Tubercle (Lond.)46 188–192 (1965).

    Google Scholar 

  • Onsted, G. D., Sbarbaro, J. A., Rotenberg, L.: Posthospital chemotherapy of the unreliable patient. Amer. Rev. resp. Dis.101 258–264 (1970).

    PubMed  Google Scholar 

  • Perret, L.: Pulmonary tuberculosis and diabetes mellitus. Scand. J. resp. Dis. Suppl.72 68–71 (1970).

    Google Scholar 

  • Pickroth, G., Anschel, R., Kalich, R., Kandt, D.: Rifampicin in the treatment of chronic pulmonary tuberculosis. Investigations on clinical activity and side effects. Acta tuberc. pneumol. belg.60 513–518 (1969).

    PubMed  Google Scholar 

  • Pines, A.: Treatment of drug-resistant tuberculosis and preliminary results obtained with rimactane. In: A Symposium on Rimactane. Basle, 1st Nov. 1968, pp. 96–99. Ciba Basel.

  • Place, V. A., Pyle, M. M., Huerga, J. de la: Ethambutol in tuberculous meningitis. Amer. Rev. resp. Dis.69 783–785 (1969).

    Google Scholar 

  • Poole, G., Stradling, P.: Intermittent chemotherapy for tuberculosis in an urban community. Brit. med. J.1 82–84 (1969).

    PubMed  Google Scholar 

  • Pyle, M. M.: Clinical applications of ethambutol. Tubercle (Lond.) Suppl.50 30–32 (1969).

    Google Scholar 

  • Radenbach, K. L., Hauck, S., Rossberg, G.: Möglichkeiten und Grenzen der Tuberkulose-Behandlung mit Kanamycin. Beitr. Klin. Tuberk.125 78–96 (1962).

    Google Scholar 

  • —— Results of clinical studies with capreomycin, ethambutol and rifampicin in the Heckeshorn Hospital, Berlin. Scand. J. resp. Dis. Suppl.69 43–53 (1969 a).

    Google Scholar 

  • —— Vermeidbare Fehler der antituberkulösen Chemotherapie. Beitr. Klin. Tuberk.140 128–141 (1969 b).

    Google Scholar 

  • —— Konservative Behandlung der Urogenitaltuberkulose in Klinik und Praxis. Act. Urol.1 151–163 (1970).

    Google Scholar 

  • Raleigh, J.: In: Rothstein, E., The Twenty Ninth Veterans Administration — Armed Forces Pulmonary Diseases Research Conference. Amer. Rev. resp. Dis.101 783–801 (1970).

    Google Scholar 

  • Ramakrishnan, C. V., Devadatta, S., Evans, C., Fox, W., Menon, N. K., Nazareth, O., Rahakrishna, S., Sambamoorthy, S., Stott, H., Tripathy, S. P., Velu, S.: A four-year follow-up of patients with quiescent pulmonary tuberculosis at the end of a year of chemotherapy with twice weekly isoniazid plus streptomycin or daily isoniazid plus PAS. Tubercle (Lond.)50 115–124 (1969).

    Google Scholar 

  • —— Janardhanam, B., Krishnamurty, D. V., Stoot, H., Subbamal, S., Tripathy, S. P.: Toxicity of pyrazinamide, administered one weekly in high dosage. In: Tuberculous Patients. Bull. W.H.O.39 775–779 (1968).

    Google Scholar 

  • Regli, J.: Erfahrungen mit Rimactan in der stationären Tuberkulosebehandlung. In: A Symposium on Rimactane. Basle, 1st Nov. 1968, pp. 91–95. Ciba, Basel.

  • Repo, U. K., Hellström, P.-E.: Capreomycin and ethambutol in pulmonary tuberculosis. A preliminary report. Scand. J. resp. Dis. Suppl.72 72–75 (1970).

    Google Scholar 

  • Riess, W.: The optimum dosage schedule for rimactane. A Symposium on rimactane, Ciba. Basel, 1st Nov. 1968, pp. 36–42.

  • Riska, N., Rinne, T.: Rifampicin in the treatment of tuberculosis. Scand. J. resp. Dis. Suppl.74 11 (1970).

    Google Scholar 

  • Rist, N.: Le thioamide de l'acide alpha-éthylisonicotinique (1314 TH). Bull. Un. int. Tuberc.28 220–228 (1958).

    Google Scholar 

  • -- La résistance du bacille tuberculeux à la rifampicine. Rev. Tuberc. (Paris)33 bis, 33–37 (1969).

  • Robitzek, E. H., Selikoff, F. J., Ornstein, G. G.: Chemotherapy of human tuberculosis with hydrazine derivates of isonicotinic acid. Quart. Bull. Sea View Hosp.13 27–51 (1952).

    Google Scholar 

  • Rothstein, E.: The Twenty-ninth Veterans-Administration Pulmonary Disease Research Conference (Cincinnati, Ohio, Jan. 26 to 28, 1970). Amer. Rev. resp. Dis.101 783–801 (1970).

    Google Scholar 

  • Sbarbaro, J. A., Johnson, S.: Tuberculous chemotherapy for recalcitrant outpatients administered directly twice weekly. Amer. Rev. resp. Dis.97 895–903 (1968).

    PubMed  Google Scholar 

  • Schonell, M. E., Crofton, J. W., Stuart, A. E., Wallace, A.: Disseminated infection with mycobacterium avium: Part I — Clinical features, treatment and pathology. Tubercle (Lond.)49 12–30 (1968).

    Google Scholar 

  • Schütz, I.: A comparison of rifampicin, ethambutol and PAS in short-term monotherapy. (Preliminary results of the third cooperative study of the WATL). Acta tuberc. pneumol. belg.60 437–441 (1969).

    PubMed  Google Scholar 

  • —— Bartmann, K., Radenbach, K. L., Siegler, W.: Vergleich der Verträglichkeit von Prothionamid und Ethionamid im Doppelblindversuch. Beitr. Klin. Tuberk.140 296–303 (1969).

    Google Scholar 

  • —— Radenbach, K. L., Bartmann, K.: The combination of ethambutol, capreomycin and a third drug in chronic pulmonary tuberculosis with bacterial polyresistance. Antibiotica et chemotherapia, vol. 16, pp. 43–58. Basel-München-New York: Karger 1970.

    Google Scholar 

  • Schwartz, W. S., Tucker, W. S.: Kanamycin in the treatment of pulmonary tuberculosis. Bull. Un. int. Tuberc.30 322–327 (1960).

    Google Scholar 

  • Sellergren, T. L.: Relapse of tuberculosis in relation to previous treatment. Scand. J. resp. Dis. Suppl.72 76–82 (1970).

    Google Scholar 

  • Selkon, J. B.: “Atypical” mycobacteria: A review. Tubercle (Lond.) Suppl.50 70–78 (1969).

    Google Scholar 

  • Somner, A. R.: Drug resistant tuberculosis treated with ethambutol and rifampicin in North East England. Tubercle (Lond.)51 222 (1970).

    Google Scholar 

  • —— Brace, A.: Ethionamide, pyrazinamide, and cycloserine used successfully in the treatment of chronic pulmonary tuberculosis. Tubercle (Lond.)43 345–360 (1962).

    Google Scholar 

  • Stewart, S. M., Murdoch, J. McC., Crofton, J. W., Hay, D.: Pyrazinamide together with oxytetracycline in patients with tubercle bacilli resistant to streptomycin, PAS and isoniazid. Brit. J. Tuberc.51 158–167 (1957).

    Google Scholar 

  • Stradling, P., Poole, G. W.: Twice weekly streptomycin plus isoniazid for tuberculosis. Tubercle (Lond.)51 44–47 (1970).

    Google Scholar 

  • Strandgaard, E.: Pulmonary tuberculosis in elderly and aged patients. Scand. J. resp. Dis. Suppl.72 83 (1970).

    Google Scholar 

  • Symposium sur les thioamides — leur place actuelle dans la lutte contre la tuberculose. Symposium tenu à l'occasion de la XXe Conférence de l'Union Internationale contre la Tuberculose à New York, le 3 Septembre 1969 (Modérateur E. Jančík, Rédaction E. Jančík, J. K. Kraan). Paris: (sous presse, Paris).

  • Tacquet, A., Devulder, B.: Ethambutol in the treatment of pulmonary tuberculosis. Rev. Tuberc. (Paris)32 729–748 (1968).

    Google Scholar 

  • -- -- Martin, J. C., Daniel, H. Mme, Le Bouffant, L.: Activité antimycobactérienne de la rifampicine. Rev. Tuberc. (Paris)33 bis, 61–80 (1969).

  • -- Savinel, E., Devulder, B., Duthot, A.: La rifampicine dans le traitement de la tuberculose pulmonaire (note préliminaire). Rev. Tuberc. (Paris)33 bis, 135–146 (1969).

  • Tala, A.: Treatment of pulmonary diseases of elderly patients in hospital. Scand. J. resp. Dis. Suppl.74 8 (1970).

    Google Scholar 

  • Tani, P.: Medical and social aspects of chronic pulmonary tuberculosis in Finland. Scand. J. resp. Dis. Suppl.72 93–105 (1970).

    Google Scholar 

  • Toušek, J.: First experience with rifampicin in retreatment of resistant cases. Acta tuberc. pneumol. belg.60 478–481 (1969).

    PubMed  Google Scholar 

  • —— Zelenka, M., Jančík, E.: Therapeutic possibilities in patients with pulmonary tuberculosis excreting tubercle bacilli resistant to INH, SM and PAS. Rozhl. Tuberk.29 398–413 (1969).

    Google Scholar 

  • —— Zítková, L., Čelíkovská, M., Štastná, J.: Prothionamide in clinical application. Stud. pneumol. phtiseol. csl.30 13–21 (1970).

    Google Scholar 

  • Trnka, L.: Mechanism of rifampicin action on mycobacterial cells. Considerations to the potentiation problem of antimycobacterial treatment. Acta tuberc. pneumol. belg.60 356–365 (1969).

    PubMed  Google Scholar 

  • Tuberculosis Chemotherapy Centre, Madras: A concurrent comparison of home and sanatorium treatment of pulmonary tuberculosis in South India. Bull. W. H. O.21 51–144 (1959).

    Google Scholar 

  • Tuberculosis Chemotherapy Centre, Madras: A concurrent comparison of home and sanatorium treatment of pulmonary tuberculosis in South India. Tubercle (Lond.)40 468–478 (1959).

    Google Scholar 

  • —— Bull. W. H. O., Lancet,1959 II 1; 23, 535–585 (1960);31, 247 (1964);34, 483 (1966).

    Google Scholar 

  • Tuberculosis Society of Scotland: Prednison in the treatment of tuberculosis controlled trial. Brit. med. J.2 1131 (1957).

    Google Scholar 

  • Tucker, W. B.: Re-treatment of advanced pulmonary tuberculosis with viomycin. Amer. Rev. Tuberc.70 812–840 (1954).

    Google Scholar 

  • —— The evolution of the cooperative studies in the chemotherapy of tuberculosis of the Veterans Administration and Armed Forces of the U.S.A. Tuberc. Res.10 1–68 (1960).

    Google Scholar 

  • —— Matthews, J. H.: Pyrazinamide used with INH in the treatment of pulmonary tuberculosis. Bull. Un. int. Tuberc.29 549–555 (1959).

    Google Scholar 

  • United States Public Health Service — Tuberculosis Study Group: Preliminary observations from a controlled trial of prednisone in the treatment of tuberculosis. Amer. Rev. resp. Dis.81 598–600 (1960).

    Google Scholar 

  • United States Public Health Service Tuberculosis Therapy Trial: Ethambutol in re-treatment of pulmonary tuberculosis. Amer. Rev. resp. Dis.98 825–836 (1968).

    Google Scholar 

  • Vall-Spinosa, A., Lester, W., et al.: In: Rothstein, E.: The twenty ninth Veterans Administration — Armed Forces Pulmonary Diseases Research Conference. Amer. Rev. resp. Dis.101 783–801 (1970).

    Google Scholar 

  • Velu, S., Sambamoorthy, S.: A Note on the Relapse rate over a 4-year period in patients with quiescent pulmonary tuberculosis following treatment with reserve regimens. Tubercle (Lond.)19 410–412 (1968).

    Google Scholar 

  • Véran, P., Moigneteau, C., Trichereau, R., Rist, N.: Le 1314 Th ou thioamide de l'acide alpha-éthyl-isonicotinique dans le traitement de la tuberculose cavitaire. Rev. Tuberc. (Paris)23 533–569 (1959).

    Google Scholar 

  • Verbist, L.: Rifampicin blood levels in man. Acta tuberc. pneumol. belg.60 288–298 (1969).

    PubMed  Google Scholar 

  • —— Experimental study of the activity of Rifampicin in vitro and in vivo. Tubercle (Lond.)50 327–328 (1969).

    Google Scholar 

  • —— Gyselen, A.: Antituberculous activity of Rifampicin in vitro and in vivo and the concentrations atteined in human blood. Amer. Rev. resp. Dis.68 923–932 (1968).

    Google Scholar 

  • Virchow, Chr., Flemming, J.: Combined treatment with rifampicin-ethambutol-capreomycin in chronic open pulmonary tuberculosis. Acta tuberc. pneumol. belg.60 448–470 (1969).

    Google Scholar 

  • W. A. T. L.: Kooperative kontrollierte Prüfung von Thiocarlid (DATC), PAS und Bettruhe in kurzfristiger Monotherapie bei kavernöser vorbehandelter Lungentuberkulose. Beitr. Klin. Tuberk.139 115–139 (1969).

    Google Scholar 

  • Weill, G., Varin, E., Stoeckel, Ch.: La rifampicine dans le traitement de la tuberculose pulmonaire. Rev. Tuberc. (Paris)33 283–290 (1969).

    Google Scholar 

  • Yeager, R. L., Munroe, W. C. C., Dessau, F. I.: Pyrazinamide (Aldinamide) in the treatment of pulmonary tuberculosis. Amer. Rev. Tuberc.65 523–534 (1952).

    Google Scholar 

  • Zaki, M. H., Edelstein, S., Josephson, R. A., Weisberg, S. R.: Regularity of drug administration among hospitalized and ambulatory tuberculous patients. Amer. Rev. resp. Dis.97 136–139 (1968).

    Google Scholar 

  • Zelenka, M., Jančík, E.: Viomycinsulfat und Viothenat — toxische und Nebenerscheinungen bei Behandlung von chronischen Tuberkulosefällen. Tuberk.-Arzt16 500–505 (1962).

    Google Scholar 

  • Zierski, M.: Die Behandlung der Lungentuberkulose bei resistenten Tuberkelbakterien. Beitr. Klin. Tuberk.125 15–21 (1962).

    Google Scholar 

  • —— The treatment of drug resistant chronic pulmonary tuberculosis with new tuberculostatics. Bull. Un. int. Tuberc.41 194–200 (1968).

    Google Scholar 

  • —— Zachara, A.: Late results in re-treatment of patients with pulmonary tuberculosis. Tubercle (Lond.)51 172–177 (1970).

    Google Scholar 

  • —— —— Woźniak, S.: Results of treatment with triple-drug regimes of reserve drugs in cavitary pulmonary tuberculosis. A study under the auspices of the International Union against Tuberculosis. Gruźlica36 809–818 (1968) (zit. Amer. Rev. resp. Dis.99, 638–639, 1969).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Gorechtkade 6, Groningen, Niederlande

    E. Jancik

Authors
  1. E. Jancik
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jancik, E. Bilanz der Chemotherapie der Tuberkulose. Pneumologie 145, 305–323 (1971). https://doi.org/10.1007/BF02095045

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02095045

Search

Navigation